Literature DB >> 3629280

Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta.

J P Devogelaer, J Malghem, B Maldague, C Nagant de Deuxchaisnes.   

Abstract

A 12-year-old female suffering from osteogenesis imperfecta (OI) was treated with 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) orally, 250 mg daily, for periods of 2 months, alternating with periods of 2 months of abstinence. Total duration of therapy was 1 year. Radiological and clinical improvement was striking. Furthermore, X-rays of the bones showed large, parallel radio-opaque striae, corresponding exactly to the periods of therapy. These were present in all metaphyses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3629280     DOI: 10.1007/BF00350961

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  9 in total

1.  THE EFFECTS OF SODIUM FLORIDE ON CALCIUM METABOLISM OF SUBJECTS WITH METABOLIC BONE DISEASES.

Authors:  C RICH; J ENSINCK; P IVANOVICH
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

2.  Osteogenesis imperfecta. Therapeutic challenge.

Authors:  S H Pierog; V J Fontana; A Ferrara
Journal:  N Y State J Med       Date:  1969-01-15

3.  Long-term treatment of osteogenesis imperfecta tarda in adults with salmon calcitonin and calcium.

Authors:  I Zanzi; S Wallach; K J Ellis; J F Aloia; H L Atkins; S H Cohn
Journal:  Curr Ther Res Clin Exp       Date:  1976-02

4.  Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda.

Authors:  R Baron; J M Gertner; R Lang; A Vignery
Journal:  Pediatr Res       Date:  1983-03       Impact factor: 3.756

5.  Characteristics and bisphosphonate treatment of a patient with juvenile osteoporosis.

Authors:  K Hoekman; S E Papapoulos; A C Peters; O L Bijvoet
Journal:  J Clin Endocrinol Metab       Date:  1985-11       Impact factor: 5.958

6.  Osteogenesis imperfecta: an expanding panorama of variants.

Authors:  D Sillence
Journal:  Clin Orthop Relat Res       Date:  1981-09       Impact factor: 4.176

7.  Wormian bones in osteogenesis imperfecta and other disorders.

Authors:  B Cremin; H Goodman; J Spranger; P Beighton
Journal:  Skeletal Radiol       Date:  1982       Impact factor: 2.199

8.  Iliac bone histomorphometry in adults and children with osteogenesis imperfecta.

Authors:  L G Ste-Marie; S A Charhon; C Edouard; M C Chapuy; P J Meunier
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

9.  Effect of long-term calcitonin therapy on the clinical course of osteogenesis imperfecta.

Authors:  E Rosenberg; R Lang; V Boisseau; S Rojanasathit; L V Avioli
Journal:  J Clin Endocrinol Metab       Date:  1977-02       Impact factor: 5.958

  9 in total
  18 in total

Review 1.  Biphosphonates.

Authors:  J Allgrove
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

Review 2.  Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.

Authors:  P Trejo; F Rauch
Journal:  Osteoporos Int       Date:  2016-08-05       Impact factor: 4.507

Review 3.  Osteogenesis imperfecta: diagnosis and treatment.

Authors:  A Biggin; C F Munns
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

4.  Bone densitometry in pediatric patients treated with pamidronate.

Authors:  Leslie E Grissom; Heidi H Kecskemethy; Steven J Bachrach; Charles McKay; H Theodore Harcke
Journal:  Pediatr Radiol       Date:  2005-01-18

Review 5.  Long-Term Bisphosphonate Therapy in Osteogenesis Imperfecta.

Authors:  A Biggin; C F Munns
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

6.  Radiographic features of bisphosphonate therapy in pediatric patients.

Authors:  Leslie E Grissom; H Theodore Harcke
Journal:  Pediatr Radiol       Date:  2003-02-15

Review 7.  Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis.

Authors:  J Thornton; D M Ashcroft; M Z Mughal; R A Elliott; T W O'Neill; D Symmons
Journal:  Arch Dis Child       Date:  2006-05-11       Impact factor: 3.791

Review 8.  Osteogenesis imperfecta: practical treatment guidelines.

Authors:  F Antoniazzi; M Mottes; P Fraschini; P C Brunelli; L Tatò
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

Review 9.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

10.  Osteogenesis imperfecta in adults: phenotypic characteristics and response to treatment in an Irish cohort.

Authors:  E S O'Sullivan; S van der Kamp; M Kilbane; M McKenna
Journal:  Ir J Med Sci       Date:  2013-08-06       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.